Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia

Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1141. doi: 10.55563/clinexprheumatol/73gejg. Epub 2021 Mar 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • Methylprednisolone*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab
  • Methylprednisolone